Nicola Gökbuget

23.9k citations
179 papers · 9.1k indexed · 5 hit papers · h-index 49
Topics
Acute Lymphoblastic Leukemia research (158 papers)Chronic Myeloid Leukemia Treatments (93 papers)Chronic Lymphocytic Leukemia Research (39 papers)

In The Last Decade

Nicola Gökbuget

166 papers receiving 8.9k citations

Hit Papers

Inotuzumab Ozogamicin versus Standard Therapy for Acute L...201420262018202220162018201420172024250500750

Peers

Nicola Gökbuget
Comparison fields: 5 of 100
  • Public Health, Environmental and Occupational Health 5.9k
  • Hematology 4.7k
  • Oncology 3.8k
  • Pathology and Forensic Medicine 1.8k
  • Pediatrics, Perinatology and Child Health 1.6k
Replace Anthony S. Stein with:
Anthony S. Stein United States
Anthony V. Moorman United Kingdom
Miloslav Beran United States
Norbert Claude Gorin France
Gerhard Zugmaier Germany
Auayporn Nademanee United States
W M Crist United States
Georg Mann Austria
Nicolas Boissel France
David A. Rizzieri United States
Nicola Gökbuget relative to Anthony S. Stein United States Anthony S. Stein's profile →
Citations per field
00.5×3.2×
Anthony S. Stein · 1×
Citations per year

Countries citing papers authored by Nicola Gökbuget

Since Specialization
Citations

This map shows the geographic impact of Nicola Gökbuget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Gökbuget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Gökbuget more than expected).

Fields of papers citing papers by Nicola Gökbuget

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Gökbuget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Gökbuget. The network helps show where Nicola Gökbuget may publish in the future.

Co-authorship network of co-authors of Nicola Gökbuget

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Gökbuget. A scholar is included among the top collaborators of Nicola Gökbuget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Gökbuget. Nicola Gökbuget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 2
4 19
5 28
6 33
7 37
8
Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemiabreakdown →
516
9
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Studybreakdown →
298
10 63
11 10
12 4
13 143
14 34
15 18
16 98
17 30
18 103
19 21
20 62

About Nicola Gökbuget

Nicola Gökbuget is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics, having authored 179 papers that have together received 9.1k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (158 papers), Chronic Myeloid Leukemia Treatments (93 papers) and Chronic Lymphocytic Leukemia Research (39 papers). The work is most often cited by research in Hematology (4.7k citations), Public Health, Environmental and Occupational Health (5.9k citations) and Oncology (3.8k citations). Nicola Gökbuget has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Dieter Hoelzer, Monika Brüggemann, D. Hoelzer, Matthias Stelljes, Stefan Schwartz, Max S. Topp, Heinz‐August Horst, Hagop M. Kantarjian, Michael Kneba and Giovanni Martinelli. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026